Member Info for lukehere

Are you in the construction industry sharkfinsoup ? Your expertise in fabrication would suggest as much. No interested investor in BYOT is unaware that the KC agreement is currently no longer proceeding as planned. The Dettol situation and its questionable claim is fact,not a rumour.(British-produced Dettol Disinfectant Liquid Lime & Lemongrass and Domestos Extended Germ-kill have been recalled by South Africa's National Regulator for Compulsory Specifications (NCRS) Byotrol has not !! Our holdings have not bee diluted close to your predicted 6 pence,nor are the wheels falling off. The current state of play at Byotrol is more encouraging than at any time in its brief history.

The percentage kill is actually 99.99%,just shortened for convenience sake. Certainly boiling water(not just hot)is also effective,yet not practical in every case. Good luck with your undue pessimism.It is a quirk of the game that a falling SP encourages bears to berate us with their views,just as optimistic comment will dominate if and when we see some recovery.

"Our products are intended to be paradigm shifting-offering a new challenge to the opposition."(BYOTROL) Such paradigm shifts are not an overnight phenomena. Nevertheless,Byotrol,with its UNPARRALLED NANOTECHNOLOGY DELIVERING A 99.9 % KILL RATE OF ALL KNOWN MICROBES ON THE BACK OF ITS 5TH GENERATION POLYMER BACKBONE,BYOTROL SEEMS DESTINED TO BECOME A HOUSEHOLD NAME ACROSS THE GLOBE,as its unique properties steadily gain recognition . We have a company whose revenues are already "accelerating" and where the pace of growth is destined to increase as new contracts start to generate significantly higher momentum. Albaad, +M.S,+A.D.M. and others will all come on stream over the next 12 months,whilst other significant agreements are due to be announced. 7.25 pence has the look of a startlingly good entry or adding level.

Figures for the year to March 31st will be released next Tuesday,June 25th.

I have just Emailed Dr Millar asking that very same question Yes2014. No reply as yet. On the positive side the MMs' will take 100k Byotrol at a price of 8.4pence.

Sorry about the last posting, Byotrol prelims scheduled for tomorrow, June 18th.

Quick Picks Quick Tools Home Share Prices Stock Picker Financial Diary UK Indices UK Industry Sectors Company Lookup Share Risers Share Fallers Broker Ratings Finance Glossary SMS Services Share Chat Finance News Blogs Live Prices Shares Bookshop Finance Tools Members Portfolio Watchlist SMS Management Premium Services What’s New User Settings Logout Latest Share Chat FRR. ....and dreaming already! FRR. Just shows you how much times hav.. TE01. yes,i had a c- uckle at that to.lo.. FRR. I think 1st class is now 60p. JLP. Not at present- . Jubilee would be .. SOLO. Anyone who co- es on a share messa.. MPLE. ok.. TE01. Philski's new- name is Philately l.. FRR. No idea anymor- e, remember it use .. MPLE. Very big!!! Home::Share Prices::Byotrol Share Price::Byotrol Share Chat Byotrol Share Chat (BYOT) BYOT Share Price BYOT Share News BYOT Share Charts BYOT Share Chat BYOT Share Trades BYOT RNS BYOT Directors Deals BYOT Live Share Price BYOT Broker Ratings Get BYOT SMS Updates BYOT Financial Diary BYOT Fundamentals BYOT Level 2 Console BYOT Media Share Price: 8.625 Bid: 8.25 Ask: 8.50 Change: 0.25 (+2.99%) Spread: 0.25 Spread as %: 3.03% Open: 8.375 High: 8.375 Low: 8.00 Yesterday’s Close: 8.375 Share Discussion for Byotrol (BYOT) Regular Share Chat Premium Share Chat Filters Thread View sharkfinsoup,Good to see that your opinion has moved from "Strong Sell" to just "Sell". I am very sad to hear of the "Rumours of loss of key staff to les competiteurs francais amid internal squabbling. " Do let us know should they turn out to be just malicious invention.

Further news on Byotrol's continued progress towards becoming THE world's leading specialist anti-microbial formulation was forthcoming last week when it was announced that as part of the US$ 17 million initiative co-funded by the Bill & Melinda Gates Foundation and USAID’s Development Innovation Ventures (DIV),a grant had been made to Bear Valley Ventures Ltd. is to test new anti-microbial hand cleaning products, based on Byotrol TM, for poor urban families in India who have limited access to water. The DIV grant runs for 12 months and is a rare thing – early stage funding for a commercial solution to a social problem. Imo investors would be well served by taking advantage of the current share price weakness and buying any available stock.

What a jaundiced view ! IF your assertion that," the competition (and yes there is better out there now) is moving at pace",were in any way true, then nobody told Kimberly Clark, Rentokil Initial, the NHS, Medilink, Albaad, Marks and Spencer, The World Health Organisation, Archer Daniels Midland and a host of others. Move on by all means. Yet you may well rue the day should you choose,or have chosen,to sell.

rugs.Difficult to see the seller being Ruffer as they like to keep their holding right up against the 30% mark.Possibly one of the instis clearing out a sub 3% position. I do though know who has been buying a goodly proportion of those sells !!

Byotrol newsflow is good and about to get better. Byotrol itself is gaining increasing global traction. The chart screams," upward breakout". The MMs' are bidding well above the quote for stock today. GOING UP !!

I posted news of this US trial(over on ADVFN)today which is shortly due to be concluded. A favourable outcome (and the portents imo are exceedingly favourable)would bring Byotrol decisively to the forefront of global perception as being THE choice for every aspect of antimicrobial control. Organization: Program for Appropriate Technology in Health (PATH) Organization Location: Seattle, WA USA "A new sanitizer and disinfectant, Byotrol, delivers broad-spectrum, long-lasting, antimicrobial control in a water-based foaming formulation, making it potentially more acceptable to providers. Integrating the use of Byotrol in facility-based birthing can lead to cleaner, safer, and more comfortable birthing environments for mothers, infants, and attendants. Under this two-year seed grant, we will evaluate the use of Byotrol versus standard practice and World Health Organization-recommended formulations for hand hygiene and device and surface disinfection in low-resource settings. Study endpoints will include provider acceptability, attendant compliance, antimicrobial efficacy, and feasibility of integrating the Byotrol product into the health system. Byotrol offers a plausible way to lower neonatal and maternal mortality due to infection and could be easily integrated into a health systems solution set." This two year N. American grant funded evaluation is due to conclude shortly. A favourable outcome could be MASSIVE for Byotrol in the USA. Interestingly,infant mortality rates have already been shown to decrease when utilised at a N.African clinic and this success has served to generate more significant orders from the general N.African healthcare market. I believe Byotrol is the most unappreciated stocks in the market today. Its potential appears virtually unlimited.

Very recently,Byotrol announced a full licensing agreement between BCP and Fortune 150 partner Kimberly-Clark(Revenues/2012/US$20Billion) . The new, seven-year contract is global in scope, with some exceptions including certain EU markets, and provides Kimberly-Clark exclusive intellectual property rights.Several top UK companies have also commenced utilising Byotrol,including Rentokil, Initial PLC ,M&S, Office Depot, Greenhams, Needlers and Sainsbury's,whilst others are considering doing so. Byotrol additionally has just secured a maiden,non-exclusive agreement to service the antimicrobial control needs of the NHS in the UK; long considered by early investors to be the "Holy Grail" of targets for BYOTROL. Byotrol have also now released the news that they have established an initial supply position in the UK with the global food processor ADM(Revenues/2012/US$80 Billion)". Archer Daniels Midland operate 265 processing plants; converting corn, oilseeds, wheat and cocoa into products for food, animal feed, industrial and energy uses. The ADM contract could be a game changer for BYOT if and when the supply agreement goes global. It is my opinion that neither Investors,nor the Market has yet,in any way,begun to appreciate the impact on revenues that the recently signed off contracts with Kimberly-Clark,the NHS and Archer Daniels Midland(to name but a few)will generate. The endorsement of Byotrol technology by such global heavyweights will present the best of testimonials to other potential international partners.

In the recent interim results,Dr Gary Millar also mentioned that at Byotrol, "we are particularly pleased to have established an initial supply position in the UK with the global food processor ADM". Archer Daniels Midland operate 265 processing plants; converting corn, oilseeds, wheat and cocoa into products for food, animal feed, industrial and energy uses. A global entity,ADM generated revenues exceeding £50 BILLION in 2012. The ADM contract could be a game changer for BYOT if and when the supply agreement goes global. Byotrol shares appear way too low imo. We could, in consequence, be looking at an imminent upward re-rating of some significance .

Eh29...Its been posted before,yet this was a Government statement:- "Low cost photovoltaic panels capable of producing twenty times more power than standard cells are under development in Wales and could cut the financial payback time from ten years to just twelve months. The collaborative industrial research project by Swansea University, Swansea based Pure Wafer Solar and Gwent Electronic Materials (GEM) aims to have a full-scale pilot production line up and running within eighteen months. The intention is then to set up a manufacturing facility capable of processing more than 2MW per annum – enough to generate power for more than 1000 homes. It currently takes about ten years to recoup the cost of installing a PV system but the short financial payback and the low cost of these panels will make it economically attractive for businesses and investors. The Welsh Government Academic Expertise for Business (A4B) programme is backing the innovative industrial collaboration. A4B is EU funded and supports highly innovative collaborative R&D projects between academia and industry to bring new high value products and processes to the market. Novel nano-materials and advanced manufacturing processes will be utilised to create a clean and affordable energy supply using reclaimed silicon integrated into a low cost Concentrating PV (CVP) panel that intensifies the light focussed on to the cells, generating more power. Rather than trying to increase the efficiency of PV cells through a complex and expensive process, the aim is to increase the intensity of light that hits the cell using low cost nano scale lenses. Business Minister Edwina Hart said that in the current economic climate it is more important than ever that Welsh industry takes advantage of the innovation and know how provided by academic research."

8-9pence podsy , I WISH. 4.5 middle would be a start. Never has a share price achieved so many false dawns. Possible that is to encourage weak holders to sell on the next upward move.

Thanks eh29.I believe Gwent are currently involved in two pieces of research for PUR,although there have not been any updates for some time now..See what you can find.Thanks.

Thanks eh29. Could you expand on the detail as we are a bit short on facts. Are we talking Gwent? Cheers

Mortgaging to save any value left in his 80% stake. This company is DOOMED.imo

I think the grants are received sporadically,in response to corporate activity,rather than in a set rythm.